Blocking CD47 accelerates hematoma removal by promoting erythrophagocytosis by macrophages, and injection of CD47 knockout blood also favors clot resolution when compared to WT blood in ICH (Ni et al., 2016; Jing et al., 2019). Here, CD47 is linked to hematoma.